Depression and Anxiety Trial, Recruiting NCT07102147 Sponsor: Abramson Cancer Center at Penn Medicine Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07102147
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You are currently receiving care for lung cancer (either treatment or follow-up care) at Penn Medicine Thoracic Oncology
  • You have been referred by a Penn Medicine Thoracic Oncology doctor or care team to receive support for depression, anxiety, or other mental health concerns

Who may not be able to join:

  • You are already receiving talk therapy or psychotherapy services outside of Penn Medicine's own collaborative care program (called Penn Integrated Care)
  • You have a serious untreated physical health condition or mental health condition — such as another cancer, schizophrenia, or active thoughts of harming yourself or others — that would make you ineligible for the Penn collaborative care program (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Abramson Cancer Center at Penn Medicine
Registry
ClinicalTrials.gov
Start date
18 August 2025
Est. completion
31 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reach - Completion of the intake assessment amongst referred patients.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov